NSE filing, NSE: VISAMAN. Summary written from the filing by ALFA Finder's alert engine.
Visaman Global Sales Ltd: key numbers
- Share price
- ₹19.60
- Market cap
- ₹41.69 Cr
- Revenue (annual)
- ₹248.7 Cr
- Net profit (annual)
- ₹6.05 Cr
- P/E (TTM)
- 6.9×Sector 16.5×
- Promoter holding
- 56.56%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Visaman Global Sales Ltd
All →Visaman Global Sales Board Meeting Date
Visaman Global Sales schedules a 13 November 2026 board meeting to consider half-yearly unaudited results. The trading window stays closed until 15 November 2026.
Visaman Global Sales Credit Rating
Acuite Ratings assigned a long-term rating of 'ACUITE BBB-/Stable' and a short-term rating of 'ACUITE A3' to Visaman Global Sales Limited's Rs.100 Crore bank facilities.
- Value
- ₹100.0 Cr
Visaman Global Sales Annual General Meeting
Visaman Global Sales Limited held its 7th Annual General Meeting on September 29, 2026, where members considered financial statements and director-related resolutions.
Visaman Global Sales Price Movement Clarification
Visaman Global Sales responded to NSE's price-movement query stating no undisclosed price-sensitive information exists. The share price movement is attributed to purely market-driven conditions.
Visaman Global Sales Annual General Meeting
Visaman Global Sales Limited has issued the notice for its 7th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Visaman Global Sales Other Announcement
Visaman Global Sales Limited filed its annual Structured Digital Database compliance certificate for FY26. The company confirmed full compliance with SEBI insider trading regulations.
Other board meeting date announcements
All →VCU Data Management Board Meeting Date
VCU Data Management scheduled a board meeting for 6 November 2026. It will consider unaudited Q2 and half-year results for the period ended September 2026.
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
EFORU Entertainment Board Meeting Date
Eforu Entertainment announced a board meeting on 05 November 2026 to consider unaudited quarterly and half-year results. Results remain unreported until the meeting is held.
Alpine Housing Development Corporation Board Meeting Date
Alpine Housing Development will hold a board meeting on 13 November 2026 to approve unaudited results for the quarter ended 30 September 2026. The trading window is closed from 1 October to 15 November 2026.
Mafia Trends Board Meeting Date
Mafia Trends will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results are declared.
Paras Healthcare Board Meeting Date
Paras Healthcare will hold a board meeting on 5 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.